Bringing the fundamentals into focus…
Back to Dianthus Therapeutics, Inc.
How Dianthus Therapeutics, Inc. stacks up
DNTH · against 454 other Healthcare companies listed in US-listed
Growth
5/ 100
Near the bottom of its peers.
Ranked #423 of 455 · scores higher than 6% of peers
Bars: peers in each 10-point band of the growth score44 peers with a growth score of 0–9, including DNTH · Click a bar to see the companies
Why growth scores 5?
Weighted metrics compared with all Healthcare companies.Mainly because of its revenue growth and 3-year revenue growth, which are weaker than most Healthcare peers.
- slower revenue growth over the last year: weaker than 97% of peers. Revenue growth: -67.3% vs peer median 6.1%
- slower revenue growth over three years: weaker than 96% of peers. 3-year revenue growth: -31.8% vs peer median 5.8%
- Still loss-making, but the loss per share narrowed. Earnings per share growth: — vs peer median 9.8%
Metric by metric
Position: dot = DNTH, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | DNTH | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Revenue growthHigher is better · 475 reported | -67.3% | 11.0% | 7% | 33% | |
| Earnings per share growthHigher is better · 171 reported | Not reported | 21.2% | — | — | 33% |
| 3-year revenue growthHigher is better · 433 reported | -31.8% | 11.0% | 6% | 33% |
A metric that is not reported is left out of the score; the other weights are rescaled.
Ranking by growth score
Top 5 and the companies ranked around DNTH| Rank | Company | Market cap | Growth | Overall |
|---|---|---|---|---|
| 1 | 464M USD | 100 | 53 | |
| 2 | 1.4B USD | 99 | 73 | |
| 2 | 433M USD | 99 | 81 | |
| 2 | 8.8B USD | 99 | 31 | |
| 2 | 90M USD | 99 | 27 | |
| 422 | 3.7B USD | 6 | 28 | |
| 423 | 1.7B USD | 5 | 23 | |
| 423 | 551M USD | 5 | 20 | |
| 423 | 4.8B USD | 5 | 27 | |
| 423 | 4.6B USD | 5 | 29 | |
| 423 | 952M USD | 5 | 3 | |
| 423 | 264M USD | 5 | 24 | |
| 423 | 91.2B USD | 5 | 18 | |
| 423 | 26.0B USD | 5 | 28 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score